Saba Capital Management, L.P. - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 18 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Saba Capital Management, L.P. ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q4 2022$12,439,491
+1.7%
1,212,4260.0%0.17%
+21.7%
Q3 2022$12,233,000
+7.8%
1,212,426
+7.1%
0.14%
+4.5%
Q2 2022$11,347,000
+54.5%
1,132,426
+54.3%
0.13%
+25.7%
Q1 2022$7,342,000
+15.8%
733,826
+14.7%
0.10%
+9.4%
Q4 2021$6,340,000639,7580.10%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q1 2023
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,103$1,177,7820.32%
METEORA CAPITAL, LLC 169,897$1,841,6830.31%
Mint Tower Capital Management B.V. 141,089$1,5320.24%
BERKLEY W R CORP 47,199$512,5810.03%
Shaolin Capital Management LLC 50,000$5430.02%
CLEAR STREET LLC 73,364$7970.01%
Walleye Capital LLC 47,936$520,5850.00%
Walleye Trading LLC 26,964$292,8290.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,588$114,9850.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders